BlackRock Investment Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

BlackRock Investment Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.89M	Buy	425,527 +57,622	+16%	+$242K	﹤0.01%	2249
2016 Q3	$1.72M	Buy	367,905 +66,329	+22%	+$393K	﹤0.01%	2275
2016 Q2	$1.98M	Buy	301,576 +17,567	+6%	+$124K	﹤0.01%	2109
2016 Q1	$1.81M	Buy	284,009 +3,809	+1%	+$19.5K	﹤0.01%	2075
2015 Q4	$1.69M	Buy	280,200 +1,221	+0.4%	+$6.98K	﹤0.01%	2211
2015 Q3	$1.67M	Sell	278,979 -1,381	-0.5%	-$9.59K	﹤0.01%	2210
2015 Q2	$1.92M	Buy	280,360 +36,297	+15%	+$230K	﹤0.01%	2272
2015 Q1	$1.48M	Buy	244,063 +1,604	+0.7%	+$10.7K	﹤0.01%	2246
2014 Q4	$1.68M	Sell	242,459 -2,471	-1%	-$18.2K	﹤0.01%	2162
2014 Q3	$1.99M	Buy	244,930 +5,743	+2%	+$44.9K	﹤0.01%	2006
2014 Q2	$1.95M	Sell	239,187 -7,263	-3%	-$55.1K	﹤0.01%	2091
2014 Q1	$1.93M	Buy	246,450 +3,485	+1%	+$29.5K	﹤0.01%	2068
2013 Q4	$2.15M	Sell	242,965 -3,878	-2%	-$34.6K	﹤0.01%	1977
2013 Q3	$2.07M	Buy	246,843 +11,805	+5%	+$95.6K	﹤0.01%	1934
2013 Q2	$1.75M	Buy	+235,038	New	+$1.8M	﹤0.01%	1954

Other funds holding SPPI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock Investment Management's SPPI Position: Q4 2016 in Review

BlackRock Investment Management increased its Spectrum Pharmaceuticals Inc (SPPI) stake by 16% in Q4 2016, buying an estimated $242K and bringing the position to 425,527 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2249.

BlackRock Investment Management first reported a position in SPPI in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.15M in Q4 2013. 139 funds tracked by Wall St. Rank hold SPPI as of Q4 2016.

BlackRock Investment Management held 425,527 shares of Spectrum Pharmaceuticals Inc worth $1.89M as of Q4 2016.
BlackRock Investment Management bought 57,622 Spectrum Pharmaceuticals Inc shares in Q4 2016, an estimated $242K.
Spectrum Pharmaceuticals Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2249 holding.
BlackRock Investment Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Spectrum Pharmaceuticals Inc position peaked at $2.15M in Q4 2013.
139 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.